HEADER VIRAL PROTEIN/IMMUNE SYSTEM 21-DEC-21 7TBF TITLE LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH ANTIBODIES TITLE 2 B1-182.1 AND A19-61.1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE GLYCOPROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SPIKE PROTEIN S1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HEAVY CHAIN OF SARS-COV-2 ANTIBODY B1-182.1; COMPND 8 CHAIN: H; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: LIGHT CHAIN OF SARS-COV-2 ANTIBODY B1-182.1; COMPND 12 CHAIN: L; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 4; COMPND 15 MOLECULE: HEAVY CHAIN OF SARS-COV-2 ANTIBODY A19-61.1; COMPND 16 CHAIN: D; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 5; COMPND 19 MOLECULE: LIGHT CHAIN OF SARS-COV-2 ANTIBODY A19-61.1; COMPND 20 CHAIN: E; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: S, 2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL: HEK 293F; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 19 MOL_ID: 4; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 23 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 24 EXPRESSION_SYSTEM_CELL: HEK293F; SOURCE 25 MOL_ID: 5; SOURCE 26 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 27 ORGANISM_TAXID: 9606; SOURCE 28 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, SPIKE, ANTIBODY, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE KEYWDS 2 SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR T.ZHOU,T.TSYBOVSKY,P.D.KWONG REVDAT 2 19-OCT-22 7TBF 1 JRNL REVDAT 1 30-MAR-22 7TBF 0 JRNL AUTH T.ZHOU,L.WANG,J.MISASI,A.PEGU,Y.ZHANG,D.R.HARRIS,A.S.OLIA, JRNL AUTH 2 C.A.TALANA,E.S.YANG,M.CHEN,M.CHOE,W.SHI,I.T.TENG,A.CREANGA, JRNL AUTH 3 C.JENKINS,K.LEUNG,T.LIU,E.D.STANCOFSKI,T.STEPHENS,B.ZHANG, JRNL AUTH 4 Y.TSYBOVSKY,B.S.GRAHAM,J.R.MASCOLA,N.J.SULLIVAN,P.D.KWONG JRNL TITL STRUCTURAL BASIS FOR POTENT ANTIBODY NEUTRALIZATION OF JRNL TITL 2 SARS-COV-2 VARIANTS INCLUDING B.1.1.529. JRNL REF SCIENCE V. 376 N8897 2022 JRNL REFN ESSN 1095-9203 JRNL PMID 35324257 JRNL DOI 10.1126/SCIENCE.ABN8897 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, COOT, PHENIX, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 7MM0 REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.100 REMARK 3 NUMBER OF PARTICLES : 358526 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: LOCAL REFINEMENT WITH CRYOSPARC REMARK 4 REMARK 4 7TBF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1000261972. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 SPIKE IN COMPLEX REMARK 245 WITH ANTIBODIES B1-182.1 AND REMARK 245 A19-61.1 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.50 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : BLOT FOR 2-3.5 SECONDS BEFORE REMARK 245 PLUGGING. REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : OTHER REMARK 245 MINIMUM DEFOCUS (NM) : 1100.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2100.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 105000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, H, L, D, E, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN H 1 REMARK 465 SER H 128 REMARK 465 LYS H 129 REMARK 465 SER H 130 REMARK 465 THR H 131 REMARK 465 SER H 132 REMARK 465 GLY H 133 REMARK 465 GLY H 134 REMARK 465 LYS H 214 REMARK 465 SER H 215 REMARK 465 CYS H 216 REMARK 465 ASP H 217 REMARK 465 LYS H 218 REMARK 465 GLU L 213 REMARK 465 CYS L 214 REMARK 465 GLN D 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER H 113 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN L 124 O THR L 129 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO A 384 CG PRO A 384 CD -0.460 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 384 CA - N - CD ANGL. DEV. = -9.8 DEGREES REMARK 500 PRO A 384 CA - CB - CG ANGL. DEV. = -20.7 DEGREES REMARK 500 PRO A 384 CB - CG - CD ANGL. DEV. = 25.9 DEGREES REMARK 500 PRO A 384 N - CD - CG ANGL. DEV. = -26.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 343 58.07 -94.20 REMARK 500 ALA A 348 171.96 67.04 REMARK 500 ASN A 370 52.43 -92.92 REMARK 500 ALA A 372 -160.22 70.73 REMARK 500 GLN A 414 145.14 69.39 REMARK 500 PHE A 456 69.39 61.00 REMARK 500 LEU A 461 174.83 65.36 REMARK 500 HIS A 519 50.15 37.63 REMARK 500 GLU H 65 45.66 -92.44 REMARK 500 ARG H 66 -15.24 -142.43 REMARK 500 THR H 75 -4.15 66.87 REMARK 500 SER H 112 -179.50 -172.93 REMARK 500 ALA H 114 163.49 64.82 REMARK 500 THR H 116 140.24 -172.76 REMARK 500 ALA H 136 -167.20 -170.88 REMARK 500 LEU H 138 139.65 -171.98 REMARK 500 CYS H 140 -169.22 -107.46 REMARK 500 ASP H 144 68.83 61.30 REMARK 500 GLU H 148 -52.94 115.70 REMARK 500 ASN H 155 -102.49 51.60 REMARK 500 LEU H 159 -15.33 70.66 REMARK 500 THR H 160 45.34 32.73 REMARK 500 SER H 186 1.55 -61.55 REMARK 500 THR H 191 -157.73 -154.34 REMARK 500 GLN H 192 137.41 -39.64 REMARK 500 ASN H 197 134.23 -170.55 REMARK 500 PRO H 202 44.41 -78.34 REMARK 500 SER H 203 137.70 -173.32 REMARK 500 GLU H 212 171.15 111.59 REMARK 500 SER L 31 11.42 59.66 REMARK 500 ALA L 51 -10.10 72.82 REMARK 500 ARG L 61 -1.87 84.22 REMARK 500 SER L 67 -166.69 -165.28 REMARK 500 THR L 69 20.11 -140.65 REMARK 500 GLN L 89 141.70 -170.89 REMARK 500 ALA L 111 45.13 -141.58 REMARK 500 PHE L 118 58.49 -161.15 REMARK 500 LYS L 126 46.93 -91.63 REMARK 500 SER L 127 -170.93 -176.14 REMARK 500 ASN L 138 67.10 61.85 REMARK 500 VAL L 150 -101.25 60.33 REMARK 500 ASP L 151 -168.61 -106.30 REMARK 500 SER L 156 48.41 -82.51 REMARK 500 LEU L 181 -114.75 69.55 REMARK 500 LYS L 183 -166.38 -115.03 REMARK 500 ALA L 184 -14.09 -49.98 REMARK 500 HIS L 189 52.95 -118.83 REMARK 500 ALA L 193 100.46 -160.79 REMARK 500 LEU L 201 1.41 -59.78 REMARK 500 SER L 202 -119.59 72.15 REMARK 500 REMARK 500 THIS ENTRY HAS 58 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7TB8 RELATED DB: PDB REMARK 900 THE COMPLEX CONTAINING THIS LOCALLY REFINED REGION REMARK 900 RELATED ID: EMD-25797 RELATED DB: EMDB REMARK 900 LOCALLY REFINED REGION OF SARS-COV-2 SPIKE IN COMPLEX WITH REMARK 900 ANTIBODIES B1-182.1 AND A19-61.1 DBREF 7TBF A 332 527 UNP P0DTC2 SPIKE_SARS2 332 527 DBREF 7TBF H 1 218 PDB 7TBF 7TBF 1 218 DBREF 7TBF L 1 214 PDB 7TBF 7TBF 1 214 DBREF 7TBF D 1 127 PDB 7TBF 7TBF 1 127 DBREF 7TBF E 1 107 PDB 7TBF 7TBF 1 107 SEQRES 1 A 196 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 2 A 196 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 3 A 196 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 4 A 196 SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 5 A 196 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 6 A 196 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 7 A 196 ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN SEQRES 8 A 196 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 9 A 196 TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN SEQRES 10 A 196 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 11 A 196 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 12 A 196 ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN SEQRES 13 A 196 CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR SEQRES 14 A 196 ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 15 A 196 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 16 A 196 PRO SEQRES 1 H 228 GLN MET GLN LEU VAL GLN SER GLY PRO GLU VAL LYS LYS SEQRES 2 H 228 PRO GLY THR SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 H 228 PHE THR PHE THR SER SER ALA VAL GLN TRP VAL ARG GLN SEQRES 4 H 228 ALA ARG GLY GLN ARG LEU GLU TRP ILE GLY TRP ILE VAL SEQRES 5 H 228 VAL GLY SER GLY ASN THR ASN TYR ALA GLN LYS PHE GLN SEQRES 6 H 228 GLU ARG VAL THR ILE THR ARG ASP MET SER THR SER THR SEQRES 7 H 228 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 H 228 ALA VAL TYR TYR CYS ALA ALA PRO TYR CYS SER GLY GLY SEQRES 9 H 228 SER CYS PHE ASP GLY PHE ASP ILE TRP GLY GLN GLY THR SEQRES 10 H 228 MET VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER SEQRES 11 H 228 VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY SEQRES 12 H 228 GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE SEQRES 13 H 228 PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU SEQRES 14 H 228 THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 H 228 SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SEQRES 16 H 228 SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL SEQRES 17 H 228 ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL SEQRES 18 H 228 GLU PRO LYS SER CYS ASP LYS SEQRES 1 L 215 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 L 215 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 L 215 GLN SER VAL SER SER SER TYR LEU ALA TRP TYR GLN GLN SEQRES 4 L 215 LYS PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SEQRES 5 L 215 SER SER ARG ALA THR GLY PHE PRO ASP ARG PHE SER GLY SEQRES 6 L 215 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 L 215 LEU GLU PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 L 215 TYR GLY ASN SER PRO TRP THR PHE GLY GLN GLY THR LYS SEQRES 9 L 215 VAL GLU ILE ARG ARG THR VAL ALA ALA PRO SER VAL PHE SEQRES 10 L 215 ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR SEQRES 11 L 215 ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG SEQRES 12 L 215 GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SEQRES 13 L 215 SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER SEQRES 14 L 215 LYS ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SEQRES 15 L 215 SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS SEQRES 16 L 215 GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SEQRES 17 L 215 SER PHE ASN ARG GLY GLU CYS SEQRES 1 D 127 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 D 127 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 D 127 PHE THR PHE SER SER TYR ALA PHE HIS TRP VAL ARG GLN SEQRES 4 D 127 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA VAL ILE SER SEQRES 5 D 127 TYR ASP GLY SER ASN GLN TYR TYR ALA ASP SER VAL LYS SEQRES 6 D 127 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 D 127 LEU TYR LEU GLN MET ASN SER LEU ARG ALA ASP ASP THR SEQRES 8 D 127 ALA VAL TYR TYR CYS ALA ARG ASP LEU ALA ILE ALA VAL SEQRES 9 D 127 ALA GLY THR TRP HIS TYR TYR ASN GLY MET ASP VAL TRP SEQRES 10 D 127 GLY GLN GLY THR THR VAL THR VAL SER SER SEQRES 1 E 107 ASP ILE GLN MET THR GLN SER PRO SER SER VAL SER ALA SEQRES 2 E 107 SER VAL GLY ASP ARG VAL ILE ILE THR CYS ARG ALA SER SEQRES 3 E 107 GLN GLY ILE SER SER TRP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 E 107 PRO GLY LYS ALA PRO LYS VAL LEU ILE TYR ASP ALA SER SEQRES 5 E 107 SER LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 E 107 GLY TYR GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 E 107 GLN PRO GLU ASP SER ALA THR TYR TYR CYS GLN GLN ALA SEQRES 8 E 107 LYS SER PHE PRO ILE THR PHE GLY GLN GLY THR ARG LEU SEQRES 9 E 107 GLU ILE LYS HET NAG B 1 14 HET NAG B 2 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 6 NAG 2(C8 H15 N O6) HELIX 1 AA1 PHE A 338 ASN A 343 1 6 HELIX 2 AA2 LYS A 417 ASN A 422 1 6 HELIX 3 AA3 PHE H 63 GLU H 65 5 3 HELIX 4 AA4 MET H 73 THR H 75 5 3 HELIX 5 AA5 THR D 28 TYR D 32 5 5 SHEET 1 AA1 5 ASN A 354 ILE A 358 0 SHEET 2 AA1 5 ASN A 394 ILE A 402 -1 O VAL A 395 N ILE A 358 SHEET 3 AA1 5 TYR A 508 GLU A 516 -1 O VAL A 510 N PHE A 400 SHEET 4 AA1 5 GLY A 431 ASN A 437 -1 N ILE A 434 O VAL A 511 SHEET 5 AA1 5 THR A 376 LYS A 378 -1 N LYS A 378 O VAL A 433 SHEET 1 AA2 2 LEU A 452 ARG A 454 0 SHEET 2 AA2 2 LEU A 492 SER A 494 -1 O GLN A 493 N TYR A 453 SHEET 1 AA3 2 TYR A 473 GLN A 474 0 SHEET 2 AA3 2 CYS A 488 TYR A 489 -1 O TYR A 489 N TYR A 473 SHEET 1 AA4 4 GLN H 3 GLN H 6 0 SHEET 2 AA4 4 VAL H 18 SER H 25 -1 O LYS H 23 N VAL H 5 SHEET 3 AA4 4 THR H 77 LEU H 82 -1 O MET H 80 N VAL H 20 SHEET 4 AA4 4 VAL H 67 THR H 68 -1 N THR H 68 O GLU H 81 SHEET 1 AA5 6 GLU H 10 LYS H 12 0 SHEET 2 AA5 6 MET H 108 VAL H 111 1 O MET H 108 N GLU H 10 SHEET 3 AA5 6 ALA H 88 ALA H 94 -1 N ALA H 88 O VAL H 109 SHEET 4 AA5 6 ALA H 33 GLN H 39 -1 N GLN H 39 O VAL H 89 SHEET 5 AA5 6 GLU H 46 VAL H 52 -1 O GLY H 49 N TRP H 36 SHEET 6 AA5 6 THR H 57 TYR H 59 -1 O ASN H 58 N TRP H 50 SHEET 1 AA6 4 GLU H 10 LYS H 12 0 SHEET 2 AA6 4 MET H 108 VAL H 111 1 O MET H 108 N GLU H 10 SHEET 3 AA6 4 ALA H 88 ALA H 94 -1 N ALA H 88 O VAL H 109 SHEET 4 AA6 4 ILE H 102 TRP H 103 -1 O ILE H 102 N ALA H 94 SHEET 1 AA7 2 CYS H 97 SER H 98 0 SHEET 2 AA7 2 SER H 100A CYS H 100B-1 O SER H 100A N SER H 98 SHEET 1 AA8 2 SER H 120 VAL H 121 0 SHEET 2 AA8 2 VAL H 142 LYS H 143 -1 O LYS H 143 N SER H 120 SHEET 1 AA9 3 ALA H 137 GLY H 139 0 SHEET 2 AA9 3 SER H 180 THR H 183 -1 O VAL H 182 N LEU H 138 SHEET 3 AA9 3 HIS H 164 THR H 165 -1 N HIS H 164 O VAL H 181 SHEET 1 AB1 3 VAL H 150 TRP H 154 0 SHEET 2 AB1 3 CYS H 196 HIS H 200 -1 O ASN H 199 N THR H 151 SHEET 3 AB1 3 THR H 205 VAL H 207 -1 O VAL H 207 N VAL H 198 SHEET 1 AB2 5 THR L 10 SER L 12 0 SHEET 2 AB2 5 THR L 102 GLU L 105 1 O GLU L 105 N LEU L 11 SHEET 3 AB2 5 VAL L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AB2 5 LEU L 33 GLN L 38 -1 N GLN L 38 O VAL L 85 SHEET 5 AB2 5 ARG L 45 LEU L 46 -1 O ARG L 45 N GLN L 37 SHEET 1 AB3 4 THR L 10 SER L 12 0 SHEET 2 AB3 4 THR L 102 GLU L 105 1 O GLU L 105 N LEU L 11 SHEET 3 AB3 4 VAL L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AB3 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 AB4 2 ALA L 19 SER L 22 0 SHEET 2 AB4 2 THR L 72 ILE L 75 -1 O LEU L 73 N LEU L 21 SHEET 1 AB5 4 PHE L 116 ILE L 117 0 SHEET 2 AB5 4 VAL L 133 ASN L 137 -1 O LEU L 135 N PHE L 116 SHEET 3 AB5 4 SER L 174 THR L 178 -1 O LEU L 175 N LEU L 136 SHEET 4 AB5 4 GLN L 160 VAL L 163 -1 N GLN L 160 O THR L 178 SHEET 1 AB6 3 LEU D 18 ALA D 23 0 SHEET 2 AB6 3 THR D 78 MET D 83 -1 O LEU D 79 N CYS D 22 SHEET 3 AB6 3 PHE D 68 ASP D 73 -1 N SER D 71 O TYR D 80 SHEET 1 AB7 5 GLN D 58 TYR D 60 0 SHEET 2 AB7 5 LEU D 45 ILE D 51 -1 N VAL D 50 O TYR D 59 SHEET 3 AB7 5 PHE D 34 GLN D 39 -1 N ARG D 38 O GLU D 46 SHEET 4 AB7 5 ALA D 92 ARG D 98 -1 O TYR D 95 N VAL D 37 SHEET 5 AB7 5 THR D 121 VAL D 123 -1 O VAL D 123 N ALA D 92 SHEET 1 AB8 2 ILE D 102 VAL D 104 0 SHEET 2 AB8 2 THR D 107 HIS D 109 -1 O THR D 107 N VAL D 104 SHEET 1 AB9 4 MET E 4 SER E 7 0 SHEET 2 AB9 4 VAL E 19 ALA E 25 -1 O ARG E 24 N THR E 5 SHEET 3 AB9 4 ASP E 70 ILE E 75 -1 O PHE E 71 N CYS E 23 SHEET 4 AB9 4 PHE E 62 SER E 63 -1 N SER E 63 O THR E 74 SHEET 1 AC1 2 ALA E 34 GLN E 37 0 SHEET 2 AC1 2 LYS E 45 TYR E 49 -1 O LEU E 47 N TRP E 35 SHEET 1 AC2 2 THR E 85 TYR E 86 0 SHEET 2 AC2 2 THR E 102 ARG E 103 -1 O THR E 102 N TYR E 86 SSBOND 1 CYS A 336 CYS A 361 1555 1555 2.04 SSBOND 2 CYS A 391 CYS A 525 1555 1555 2.05 SSBOND 3 CYS A 480 CYS A 488 1555 1555 2.03 SSBOND 4 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 5 CYS H 97 CYS H 100B 1555 1555 2.03 SSBOND 6 CYS H 140 CYS H 196 1555 1555 2.03 SSBOND 7 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 8 CYS L 134 CYS L 194 1555 1555 2.04 SSBOND 9 CYS D 22 CYS D 96 1555 1555 2.04 SSBOND 10 CYS E 23 CYS E 88 1555 1555 2.04 LINK ND2 ASN A 343 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.45 CISPEP 1 SER L 7 PRO L 8 0 -0.83 CISPEP 2 SER L 94 PRO L 95 0 -5.36 CISPEP 3 SER E 7 PRO E 8 0 -0.85 CISPEP 4 PHE E 94 PRO E 95 0 0.09 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000